Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Deferoxamine Mesylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,014Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mitem Pharma Acquires Rights To Desferal
    Mitem Pharma Acquires Rights To Desferal

    25 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240924810630/en

    BUSINESSWIRE
    25 Sep 2024
    Share Share
    Challenges Of Developing And Facilitating Access To New Sickle Cell Disease
    Challenges Of Developing And Facilitating Access To New Sickle Cell Disease

    15 Oct 2020

    // Joshua Cohen FORBES

    https://www.forbes.com/sites/joshuacohen/2020/10/15/challenges-of-developing-and-facilitating-access-to-new-sickle-cell-disease-therapies-case-of-the-deferoxamine-patch/#4137fbbc4289

    Joshua Cohen FORBES
    15 Oct 2020
    Share Share
    Theris Medical Launches Patient Enrollment for “Orphan Drug” Clinical Trial
    Theris Medical Launches Patient Enrollment for “Orphan Drug” Clinical Trial

    16 Sep 2020

    // WEBWIRE

    https://www.webwire.com/ViewPressRel.asp?aId=264034

    WEBWIRE
    16 Sep 2020
    Share Share
    Enforcement Report - Week of October 11, 2017
    Enforcement Report - Week of October 11, 2017

    11 Oct 2017

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-11-2017-1507696514.pdf

    FDA
    11 Oct 2017
    Share Share
    Walgreens Infusion Services, Ongoing Class III recall of Deferoxamine various strengths in normal saline because of Lack of sterility assurance.
    Walgreens Infusion Services, Ongoing Class III recall of Deferoxamine various strengths in normal saline because of Lack of sterility assurance.

    28 Jan 2015

    // FDA

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0370-2015&w=01282015&lang=eng

    FDA
    28 Jan 2015
    Share Share